HomeCompareJTSIX vs JNJ

JTSIX vs JNJ: Dividend Comparison 2026

JTSIX yields 5.39% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $1.8K in total portfolio value· pulled ahead in Year 10
10 years
JTSIX
JTSIX
● Live price
5.39%
Share price
$24.87
Annual div
$1.34
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.5K
Annual income
$760.67
Full JTSIX calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — JTSIX vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJTSIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JTSIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JTSIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JTSIX
Annual income on $10K today (after 15% tax)
$458.21/yr
After 10yr DRIP, annual income (after tax)
$646.57/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,339.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JTSIX + JNJ for your $10,000?

JTSIX: 50%JNJ: 50%
100% JNJ50/50100% JTSIX
Portfolio after 10yr
$29.4K
Annual income
$2,725.04/yr
Blended yield
9.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JTSIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JTSIX buys
0
JNJ buys
0
No recent congressional trades found for JTSIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJTSIXJNJ
Forward yield5.39%2.13%
Annual dividend / share$1.34$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$28.5K$30.3K
Annual income after 10y$760.67$4,689.40
Total dividends collected$6.5K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JTSIX vs JNJ ($10,000, DRIP)

YearJTSIX PortfolioJTSIX Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,239$539.08$10,592$272.30+$647.00JTSIX
2$12,592$566.23$11,289$357.73+$1.3KJTSIX
3$14,066$592.90$12,123$472.89+$1.9KJTSIX
4$15,670$618.99$13,141$629.86+$2.5KJTSIX
5$17,411$644.44$14,408$846.81+$3.0KJTSIX
6$19,299$669.21$16,021$1,151.60+$3.3KJTSIX
7$21,344$693.25$18,122$1,588.22+$3.2KJTSIX
8$23,554$716.52$20,930$2,228.20+$2.6KJTSIX
9$25,942$739.00$24,792$3,191.91+$1.1KJTSIX
10← crossover$28,519$760.67$30,274$4,689.40$1.8KJNJ

JTSIX vs JNJ: Complete Analysis 2026

JTSIXStock

The investment seeks high total return with a shift to current income and some capital appreciation over time as the fund approaches and passes the target retirement date. The fund is generally intended for investors who plan to retire around the year 2050 and then withdraw their investment in the fund throughout retirement. It is designed to provide exposure to equity, fixed income and cash/cash equivalent asset classes by investing in mutual funds and ETFs within the same group of investment companies, passive ETFs that are managed by unaffiliated investment advisers in certain limited instances and/or direct investments in other financial instruments.

Full JTSIX Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this JTSIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JTSIX vs SCHDJTSIX vs JEPIJTSIX vs OJTSIX vs KOJTSIX vs MAINJTSIX vs ABBVJTSIX vs MRKJTSIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.